More Articles

Mylan starts phase III trials for biosimilar insulin glargine Biosimilars/News | Posted 03/10/2014

Generics maker Mylan has started two US phase III clinical trials for a biosimilar version of French drugmaker Sanofi’s diabetes drug Lantus (insulin glargine).

Global and national biosimilars players increasing Reports | Posted 03/10/2014

The number of players in the biosimilars field is increasing with both originator and generics manufacturers devoting resources to biosimilars. This applies to global companies as well as to nation...

New indication for old generic combination drug Generics/News | Posted 03/10/2014

US biopharmaceutical company Avanir Pharmaceuticals has announced positive results from a phase II clinical trial of a generic combination drug for the treatment of agitation in patients with Alzhe...

IAPO releases toolkit for biologicals and biosimilars Biosimilars/General | Posted 03/10/2014

The International Alliance of Patients’ Organizations (IAPO), which comprises over 200 patient groups and represents the interests of patients worldwide, has published an Information and Advocacy T...

Call for action on labelling of biosimilars Biosimilars/General | Posted 26/09/2014

European trade association, the European Association for Bioindustry (EuropaBio) has called on the European Medicines Agency (EMA) to define specific guidance on the labelling of biosimilars.

The ethics of generic immunosuppressive drugs Generics/Research | Posted 26/09/2014

A literature review of generic immunosuppressive drugs (ISDs) in renal transplant patients concludes that it is ethical to prescribe generic ISDs provided regulatory safeguards are met. Alongside t...

Amgen starts phase III trial for biosimilar rituximab Biosimilars/News | Posted 26/09/2014

Biologicals major Amgen is carrying out a global phase III clinical trial for a biosimilar version of Roche’s blockbuster arthritis/non-Hodgkin’s lymphoma drug MabThera/Rituxan (rituximab).

Phase III trials for generic asthma inhaler and insulin glargine Generics/News | Posted 26/09/2014

Generics giant Mylan is set to embark on phase III clinical trials of its generic fluticasone/salmeterol inhaler for asthma patients.